Early effects of empagliflozin on exercise tolerance in patients with heart failure: A pilot study.
Julio NunezPatricia PalauEloy DomínguezAnna MollarEduardo NúñezJose María RamónGema MinanaEnrique SantasLorenzo FácilaJose Luis GórrizJuan SanchisAntoni Bayés-GenísPublished in: Clinical cardiology (2018)
In this pilot study, empagliflozin was associated with 1-month improvement in exercise capacity in T2DM patients with symptomatic HF. This beneficial effect was also found for other surrogates of severity.